Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS

Clinica Chimica Acta

Volumn 412, Issue 17-18, 2011, Pages 1606-1615

  Barnaby, Omar S ^a   Cerny, Ronald L ^a   Clarke, William ^b   Hage, David S ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

16O 18O Labeling; Diabetes; Human serum albumin; Matrix assisted laser desorption ionization time of flight mass spectrometry; Non enzymatic glycation; Quantitative proteomics

Indexed keywords

ADVANCED GLYCATION END PRODUCT; HUMAN SERUM ALBUMIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; IN VITRO STUDY; ISOTOPE LABELING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REACTION TIME; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; GLUCOSE; HUMANS; MOLECULAR SEQUENCE DATA; OXYGEN ISOTOPES; SERUM ALBUMIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79959314391     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.05.012     Document Type: Article

References (45)

1. Thornalley P.J., Langborg A., Minhas H.S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999, 344:109-116.
2. Horiuchi S. Advanced glycation end products (AGE)-modified proteins and their potential relevance to atherosclerosis. Trend Cardiovasc Med 1996, 6:163-168.
3. Araki N., Ueno N., Chakrabarti B., Morino Y., Horiuchi S. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 1992, 267:10211-10214.
4. Hodge J.E. Chemistry of browning reactions in model systems. J Agric Food Chem 1953, 1:928-943.
5. Gavin J.R., Alberti K.G.M.M., Davidson M.B., DeFronzo R.A., Drash A., Gabbe S.G., et al. Report on the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002, 25:S5-S20.
6. Lapolla A., Fedele D., Reitano R., Bonfante L., Guizzo M., Seraglia R., et al. Mass spectrometric study of in vivo production of advanced glycation end-products/peptides. J Mass Spectrom 2005, 40:969-972.
7. Lapolla A., Fedele D., Seraglia R., Traldi P. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update. Mass Spectrom Rev 2006, 25:775-797.
8. Zhang Q., Ames J.M., Smith R.D., Baynes J.W., Metz T.O. A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. J Proteome Res 2009, 8:754-769.
9. Nursten H. The Maillard reaction 2005, Royal Society of Chemistry, Cambridge, UK.
10. Monnier V.M. Nonenzymatic glycosylation, the Maillard reaction and the aging process. J Gerontol 1990, 45:B105-B111.
11. Stitt A.W., Curtis T.M. Advanced glycation and retinal pathology during diabetes. Pharmacol Rep 2005, 57:156-168.
12. --(1-corboxyethyl)lysine-modified albumin. Biochem J 2002, 364:1-14.
13. Thornalley P.J. Dicarbonyl intermediates in the Maillard reaction. Ann NY Acad Sci 2005, 1043:111-117.
14. Barzegar A., Moosavi-Movahedi A.A., Sattarahmady N. Spectroscopic studies of the effects of glycation of human serum albumin on L-trp binding. Protein Pept Lett 2007, 14:13-18.
15. Vorum H., Fisker K., Otagiri M., Pedersen A.O., Hansen U.K. Calcium ion binding to clinically relevant chemical modifications of human serum albumin. Clin Chem 1995, 41:1654-1661.
16. Koyama H., Sugioka N., Uno A., Mori S., Nakajima K. Effects of glycosylation of hypoglycemic drug binding to serum albumin. Biopharm Drug Dispos 1997, 18:791-801.
17. Shaklai N., Garlick R.L., Bunn H.F. Nonenzymatic glycosylation of human serum albumin alters its confirmation and function. J Biol Chem 1984, 259:3812-3817.
18. Mandula H., Parepally J.M.R., Feng R., Smith Q.R. Role of site-specific binding to plasma albumin in drug availability to brain. J Pharmacol Exp Ther 2006, 317:667-675.
19. Peters T. All about albumin: biochemistry, genetics, and medical applications 1996, Academic Press, San Diego.
20. Iberg N., Fluckiger R. Nonenzymatic glycosylation of albumin in vivo. J Biol Chem 1986, 261:13542-13545.
21. 13C-reducing sugars for quantitative analysis of glycated proteins in human plasma. Mol Cell Proteomics 2010, 9:579-597.
22. Ahmed N., Dobler D., Dean M., Thornalley P.J. Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J Biol Chem 2005, 280:5724-5732.
23. Joseph K.S., Hage D.S. The effects of glycation on the binding of human serum albumin to warfarin and l-tryptophan. J Pharm Biomed Anal 2010, 53:811-818.
24. Ahmed N., Thornalley P.J. Peptide mapping of human serum albumin modified by methylglyoxal in vitro and in vivo. Ann NY Acad Sci 2005, 1043:260-266.
25. 18O labeling: a tool for proteomics. Rapid Commun Mass Spectrom 2001, 15:2456-2465.
26. 18O into peptide fragments and its application for protein sequencing by electrospray and matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis 2005, 17:945-953.
27. 18O labeling and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chim Acta 2010, 411:1102-1110.
28. 18O labeling for relative quantification of differential protein complex composition. Rapid Commun Mass Spectrom 2004, 18:869-876.
29. Barnaby O.S., Cerny R.L., Clarke W., Hage D.S. Comparison of modification sites formed on human serum albumin at various stages of glycation. Clin Chim Acta 2011, 412:277-285.
30. Perkins D.N., Pappin D.J.C., Creasy D.M., Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567.
31. Atanasova M., Konova E., Betova T., Baydanoff S. Non-enzymatic glycation of human fibrillin-1. Gerontology 2009, 55:73-81.
32. Mitsuhashi T., Li Y.M., Fishbane S., Vlassara H. Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix. J Clin Invest 1997, 100:847-854.
33. Turner R.C., Cull C.A., Frighi V., Holman R.R. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. J Am Med Assoc 1999, 281:2005-2012.
34. Wa C., Cerny R.L., Clarke W.A., Hage D.S. Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chim Acta 2007, 385:48-60.
35. Wa C., Cerny R.L., Hage D.S. Identification and quantitative studies of protein immobilization sites by stable isotope labeling and mass spectrometry. Anal Chem 2006, 78:7967-7977.
36. Wa C., Cerny R., Hage D.S. Obtaining high sequence coverage in matrix-assisted laser desorption time-of-flight mass spectrometry for studies of protein modification: analysis of human serum albumin as a model. Anal Biochem 2006, 349:229-241.
37. Meier P.C., Zund R.E. Statistical methods in analytical chemistry 1993, Wiley, New York.
38. Abordo E.A., Thornalley P.J. Pro-inflammatory cytokine synthesis by human monocytes induced by proteins minimally-modified by methylglyoxal. The Maillard reaction in foods and medicine 1998, 357-362. The Royal Society of Chemistry, Cambridge, UK. J. O'Brien, H.E. Nursten, M.J.C. Crabbe, J.M. Ames (Eds.).
39. Lapolla A., Fedele D., Seraglia R., et al. A new effective method for the evaluation of glycated intact plasma proteins in diabetic subjects. Diabetologia 1995, 38:1076-1081.
40. Robb D.A., Olufemi S.O., Williams D.A., Midgley J.M. Identification of glycation at the N-terminus of albumin by gas chromatography-mass spectrometry. Biochem J 1989, 261:871-878.
41. Frolov A., Hoffmann R. Identification and relative quantification of specific glycation sites in human serum albumin. Anal Bioanal Chem 2010, 397:2349-2356.
42. Sugio S., Kashima A., Mochizuki S., Kobayashi K. Crystal structure of human serum albumin at 2.5Å resolution. Protein Eng 1999, 12:439-446.
43. Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996, 14:33-38.
44. Joseph K.S., Anguizola J., Hage D.S. Chromatographic analysis of acetohexamide binding to glycated human serum albumin. J Chromatogr B 2010, 878:2775-2781.
45. Joseph K.S., Anguizola J., Hage D.S. Binding of tolbutamide to glycated human serum albumin. J Pharm Biomed Anal 2011, 54:426-432.